TipRanks
Integrated BioPharma Inc (INBP)
OTHER OTC:INBP
US Market
INBP
Integrated BioPharma
RESEARCH TOOLSreports
Want to see INBP full AI Analyst Report?

Integrated BioPharma (INBP) Ratios

10 Followers

Integrated BioPharma Ratios

INBP's free cash flow for Q4 2026 was
lt;0.01. For the 2026 fiscal year, INBP's free cash flow was decreased by $ and operating cash flow was $-0.09. See a summary of the company’s cash flow.
Ratios
TTM
Jun 26Jun 25Jun 24Jun 23
Liquidity Ratios
Current Ratio
 3.00 3.00 4.42 2.92 3.39
Quick Ratio
 1.42 1.42 2.21 1.08 1.27
Cash Ratio
 0.77 0.77 0.85 0.27 0.27
Solvency Ratio
 -0.20 -0.19 0.45 0.19 0.17
Operating Cash Flow Ratio
 0.21 0.21 0.49 0.15 0.26
Short-Term Operating Cash Flow Coverage
 1.03 1.03 0.00 0.99 1.32
Net Current Asset Value
$ 9.71M$ 9.71M$ 14.18M$ 10.91M$ 9.80M
Leverage Ratios
Debt-to-Assets Ratio
 0.12 0.12 0.04 0.07 0.11
Debt-to-Equity Ratio
 0.17 0.17 0.05 0.09 0.14
Debt-to-Capital Ratio
 0.15 0.15 0.05 0.09 0.12
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.43 1.43 1.23 1.36 1.35
Debt Service Coverage Ratio
 -1.36 -1.31 46.15 1.31 1.18
Interest Coverage Ratio
 0.00 -225.42 43.91 4.83 3.00
Debt to Market Cap
 0.21 0.22 0.00 0.16 0.09
Interest Debt Per Share
 0.10 0.10 0.04 0.06 0.09
Net Debt to EBITDA
 1.02 1.06 -0.77 0.08 1.06
Profitability Margins
Gross Profit Margin
1.82%1.82%10.23%7.72%8.01%
EBIT Margin
-6.09%-6.17%3.88%0.50%0.24%
EBITDA Margin
-3.10%-3.00%6.21%2.93%2.51%
Operating Profit Margin
-6.17%-6.17%3.72%0.50%0.24%
Pretax Profit Margin
-5.84%-5.84%3.79%0.53%0.20%
Net Profit Margin
-6.48%-6.48%1.49%0.22%-0.07%
Continuous Operations Profit Margin
-6.48%-6.48%1.49%0.22%-0.07%
Net Income Per EBT
110.89%110.89%39.19%41.79%-34.00%
EBT Per EBIT
94.75%94.75%102.08%106.77%83.33%
Return on Assets (ROA)
-11.22%-11.22%3.24%0.43%-0.13%
Return on Equity (ROE)
-14.78%-16.09%3.98%0.58%-0.18%
Return on Capital Employed (ROCE)
-13.85%-13.85%9.78%1.25%0.58%
Return on Invested Capital (ROIC)
-13.04%-13.04%3.71%0.48%-0.18%
Return on Tangible Assets
-11.22%-11.22%3.24%0.43%-0.13%
Earnings Yield
-50.28%-50.83%7.47%1.86%-0.34%
Efficiency Ratios
Receivables Turnover
 13.16 13.16 10.01 10.78 11.23
Payables Turnover
 13.46 13.46 21.52 18.50 20.57
Inventory Turnover
 4.71 4.71 5.21 4.13 4.54
Fixed Asset Turnover
 9.09 9.09 19.77 13.69 11.85
Asset Turnover
 1.73 1.73 2.18 1.92 1.99
Working Capital Turnover Ratio
 3.65 3.36 4.14 4.32 4.42
Cash Conversion Cycle
 78.09 78.09 89.54 102.52 95.10
Days of Sales Outstanding
 27.74 27.74 36.46 33.86 32.49
Days of Inventory Outstanding
 77.47 77.47 70.04 88.39 80.35
Days of Payables Outstanding
 27.12 27.12 16.96 19.73 17.74
Operating Cycle
 105.21 105.21 106.50 122.25 112.85
Cash Flow Ratios
Operating Cash Flow Per Share
 0.04 0.04 0.07 0.03 0.04
Free Cash Flow Per Share
 0.03 0.03 0.06 0.01 0.04
CapEx Per Share
 0.01 0.01 <0.01 0.02 <0.01
Free Cash Flow to Operating Cash Flow
 0.72 0.72 0.91 0.41 0.91
Dividend Paid and CapEx Coverage Ratio
 3.59 3.59 10.81 1.71 10.62
Capital Expenditure Coverage Ratio
 3.59 3.59 10.81 1.71 10.62
Operating Cash Flow Coverage Ratio
 0.40 0.40 2.03 0.52 0.46
Operating Cash Flow to Sales Ratio
 0.03 0.03 0.04 0.02 0.02
Free Cash Flow Yield
15.83%16.01%17.33%6.49%11.29%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -1.99 -1.97 13.37 53.69 -290.69
Price-to-Sales (P/S) Ratio
 0.13 0.13 0.20 0.12 0.20
Price-to-Book (P/B) Ratio
 0.32 0.32 0.53 0.31 0.52
Price-to-Free Cash Flow (P/FCF) Ratio
 6.32 6.25 5.77 15.42 8.86
Price-to-Operating Cash Flow Ratio
 4.56 4.51 5.24 6.38 8.02
Price-to-Earnings Growth (PEG) Ratio
 0.04 <0.01 0.02 -0.12 2.88
Price-to-Fair Value
 0.32 0.32 0.53 0.31 0.52
Enterprise Value Multiple
 -3.13 -3.19 2.43 4.17 8.82
Enterprise Value
 4.26M 4.20M 8.22M 6.13M 11.24M
EV to EBITDA
 -3.13 -3.19 2.43 4.17 8.82
EV to Sales
 0.10 0.10 0.15 0.12 0.22
EV to Free Cash Flow
 4.76 4.69 4.38 15.73 10.07
EV to Operating Cash Flow
 3.43 3.38 3.98 6.50 9.12
Tangible Book Value Per Share
 0.57 0.57 0.67 0.64 0.63
Shareholders’ Equity Per Share
 0.57 0.57 0.67 0.64 0.63
Tax and Other Ratios
Effective Tax Rate
 -0.11 -0.11 0.61 0.58 1.34
Revenue Per Share
 1.41 1.41 1.79 1.67 1.69
Net Income Per Share
 -0.09 -0.09 0.03 <0.01 >-0.01
Tax Burden
 1.11 1.11 0.39 0.42 -0.34
Interest Burden
 0.96 0.95 0.98 1.07 0.83
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.08 0.08 0.07 0.00 0.00
Stock-Based Compensation to Revenue
 <0.01 <0.01 <0.01 <0.01 <0.01
Income Quality
 -0.44 -0.44 2.56 8.42 -36.24
Currency in USD